Vivek Bhaskaran is a seasoned Senior Investigator and Strategic Pre-Clinical Research Leader, currently leveraging his extensive expertise as a self-employed Preclinical Pharmacology Consultant. With a profound commitment to advancing oncology research, Vivek specializes in the development of innovative methodologies that bridge the gap between preclinical...
Vivek Bhaskaran is a seasoned Senior Investigator and Strategic Pre-Clinical Research Leader, currently leveraging his extensive expertise as a self-employed Preclinical Pharmacology Consultant. With a profound commitment to advancing oncology research, Vivek specializes in the development of innovative methodologies that bridge the gap between preclinical research and clinical trials. His role involves collaborating with early-stage biotech companies to guide them through the intricacies of drug development, ensuring that their therapeutic candidates are both safe and effective.
Vivek's extensive skill set encompasses a wide range of techniques essential for preclinical research, including cell culture, protein purification, and flow cytometry. His hands-on experience with cell-based assays and cytotoxicity testing has been instrumental in evaluating the efficacy of novel compounds, particularly in the context of brain tumors. By employing advanced methodologies such as PCR and ELISA, he has been able to generate robust data that supports the transition of promising drug candidates into clinical settings.
In his current projects, Vivek is focused on pioneering research that not only addresses the complexities of cancer biology but also integrates cutting-edge technologies to enhance drug discovery processes. His strategic insights and curriculum design capabilities enable him to mentor emerging scientists and foster a culture of innovation within the teams he collaborates with. As he continues to drive transformative research in oncology, Vivek remains dedicated to making a significant impact on the future of cancer therapeutics.
